Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide.
作者:
主题词
乳腺肿瘤(Breast Neoplasms);癌症疫苗(Cancer Vaccines);女(雌)性(Female);基因, MHCⅡ类(Genes, MHC Class II);人类(Humans);干扰素γ(Interferon-gamma);白细胞, 单核(Leukocytes, Mononuclear);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);转化生长因子β(Transforming Growth Factor beta)
DOI
10.1016/j.vaccine.2010.09.029
PMID
20858449
发布时间
2014-11-20
- 浏览20

Vaccine
7476-82页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文